^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)

i
Other names: MT-CO2, Mitochondrially Encoded Cytochrome C Oxidase II, COX2, MTCO2, COII, CO2, Cytochrome C Oxidase Polypeptide II, Cytochrome C Oxidase Subunit II, Cytochrome C Oxidase Subunit 2, Cytochrome C Oxidase II, COXII
Associations
29d
Activated CD38+ mast cells promote gastric cancer progression by suppressing CD8+ T cell cytotoxic activity through adenosine metabolism. (PubMed, Cell Rep)
Cellular interactions are more complex at the GC stage than in the premalignant lesions. Collectively, our study offers a comprehensive insight into the evolving gastric mucosal microenvironment and validates the pro-tumor role of activated mast cells under H. pylori infection.
Journal • IO biomarker
|
CD8 (cluster of differentiation 8) • CD38 (CD38 Molecule) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
1m
Exploring the Regulatory Effects of Curcumin on CD47-Overexpressing Esophageal Cancer Cells via Network Pharmacology with Preclinical Validation. (PubMed, Curr Med Chem)
This study highlights CUR's potential in treating EC, particularly in CD47 overexpression cases. These results clarify the molecular interactions and provide a basis for future research on CUR-based therapies targeting EC progression pathways.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CD47 (CD47 Molecule) • BAX (BCL2-associated X protein) • PTGS2 (Prostaglandin-Endoperoxide Synthase 2) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II) • PACERR (PTGS2 Antisense NFKB1 Complex-Mediated Expression Regulator RNA)
1m
ACSL5 Mediates Adaptation to the Palmitic Acid-Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis. (PubMed, Cancer Res)
Limiting PA intake or targeting the ACSL5/COX2/EP4 axis enhanced paclitaxel efficacy in a breast cancer mouse model. Collectively, these findings highlight the critical role of PA and ACSL5/COX2/EP4 signaling in lung metastasis, which can act as promising targets for enhancing the efficacy of chemotherapy in BC patients with lung metastasis.
Journal
|
ACSL5 (Acyl-CoA Synthetase Long Chain Family Member 5) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II) • USP47 (Ubiquitin Specific Peptidase 47)
|
paclitaxel
1m
Phloretin-induced modulation in gut microbiome, mitigates colonic inflammation and alleviates colitis-associated colorectal cancer in mice. (PubMed, Comput Struct Biotechnol J)
The increased abundance of L. reuteri and L. murinus was associated with regulated cellular proliferation, reduced TNF-α production, and decreased expression of COX-2, cyclin D1, and Bcl-2. In conclusion, the results obtained signify the nutraceutical potential of phloretin in restoring the intestinal barrier, maintaining the beneficial gut microbial population, and amelioration of CAC in mice.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CCND1 (Cyclin D1) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • PTGS2 (Prostaglandin-Endoperoxide Synthase 2) • IL1B (Interleukin 1, beta) • MUC2 (Mucin 2) • HSP90AA1 (Heat Shock Protein 90 Alpha Family Class A Member 1Heat Shock Protein 90 Alpha Family Class A Member 1) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
1m
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma. (PubMed, Hepatology)
Tumor-intrinsic activation of the NRF2-COX2-PGE₂ axis drives immune cold TMEs and mediates Atez/Bev resistance in HCC. Targeting this pathway may enhance efficacy, and plasma PGE₂ represents a non-invasive biomarker for stratification.
Journal • PD(L)-1 Biomarker • IO biomarker
|
MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
|
Avastin (bevacizumab) • Tecentriq (atezolizumab) • sorafenib
2ms
Is Cyclooxygenase 2 Effective in Breast Cancer Diagnosis? (PubMed, Asian Pac J Cancer Prev)
These results provide insight into the ability to use COX2 as a biomarker for suspected breast cancer patients in Iraq.
Journal
|
MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
2ms
Identification of novel umami peptides with anti-inflammatory and antioxidant effects in spent hen protein hydrolysate. (PubMed, Food Chem)
Two oligopeptides (5 mM) induced sustained Ca2+ responses (> 5 min), and all four reduced ROS (p < 0.0001); SKEGGKVT (50 μM) also significantly inhibited COX2 expression (p = 0.018). These findings highlight spent hens as a good source of multifunctional umami peptides.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
2ms
Discovery of selective TLR9 antagonists via machine learning-driven structural modeling and experimental validation. (PubMed, Int J Biol Macromol)
Comparative analyses indicated that TRin7 exhibited slightly greater potency, consistent with its lower binding free-energy profile in MM/PBSA calculations. Collectively, these findings establish TRin7 and TRin8 as promising small-molecule antagonists of TLR9 and highlight the utility of integrating machine learning with structural modeling and cellular validation in rational drug discovery.
Journal • IO biomarker
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • TLR9 (Toll Like Receptor 9) • NOS2 (Nitric Oxide Synthase 2) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
2ms
Advanced Glycation End Products Promote PGE2 Production in Ca9-22 Cells via RAGE/TLR4-Mediated PKC-NF-κB Pathway. (PubMed, Cells)
In conclusion, these findings demonstrate that AGEs increase PGE2 production in Ca9-22 cells primarily through a signaling cascade involving RAGE and the TLR4-PKC-NF-κB pathway. Our results suggest TLR4 as a critical mediator that contributes to AGEs-induced inflammation.
Journal • IO biomarker
|
CA9 (Carbonic anhydrase 9) • TLR4 (Toll Like Receptor 4) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
3ms
PRDX1 depletion predisposes to ferroptosis through inhibiting the cAMP pathway in B-cell acute lymphoblastic leukemia. (PubMed, Cancer Gene Ther)
Ferroptosis was induced in B-ALL cells using erastin...PRDX1 knockdown further reduced the viability of B-ALL cells treated with the ferroptosis activator ML210, and treatment with the ferroptosis inhibitor liproxstatin-1 significantly reversed the suppressive effect of PRDX1 knockdown on xenograft tumor growth. Mechanically, PRDX1 deletion triggered ferroptosis in B-ALL cells by inhibiting the cAMP pathway. PRDX1 deficiency modulates ferroptosis in B-ALL cells by blocking the cAMP pathway, which offer a novel perspective on the pathogenesis of B-ALL.
Journal
|
PRDX1 (Peroxiredoxin 1) • GPX4 (Glutathione Peroxidase 4) • ACSL4 (Acyl-CoA Synthetase Long Chain Family Member 4) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
|
erastin • ML210 • liproxstatin-1
3ms
Gut-brain axis and exosome-mediated communication in postoperative cognitive dysfunction associated with colorectal cancer. (PubMed, Acta Biochim Biophys Sin (Shanghai))
Exosomes derived from these microbiota enhance neuronal uptake and trigger markers of ferroptosis, as evidenced by increased expressions of ATG5 and COX2, along with decreased levels of GPX4 and FTH1. These findings establish a mechanistic link between microbial dysbiosis, ferroptosis, and cognitive decline in POCD, providing new insights into potential therapeutic targets for CRC-associated POCD.
Journal
|
GPX4 (Glutathione Peroxidase 4) • ATG5 (Autophagy Related 5) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)
4ms
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway. (PubMed, Mol Oncol)
Our findings uncover a new function of cytoplasmic p21 in regulating CSC properties through NFκB modulation. Screening p21 subcellular localization may stratify CRC patients with high metastatic risk providing a basis for CSC-targeted therapeutic strategies.
Journal
|
BCL2L1 (BCL2-like 1) • SOX2 • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • NANOG (Nanog Homeobox) • MT-CO2 (Mitochondrially Encoded Cytochrome C Oxidase II)